Eadon, M.T.Desta, Z.Levy, K.D.Decker, B.S.Pierson, R.C.Pratt, V.M.Callaghan, J.T.Rosenman, M.B.Carpenter, J.S.Holmes, A.M.McDonald, C.A.Benson, E.A.Patil, A.S.Vuppalanchi, R.Gufford, B.T.Dave, N.Robarge, J.D.Hyder, M.A.Haas, D.M.Kreutz, R.P.Dexter, P.R.Skaar, Todd C.Flockhart, D.A.2018-03-162018-03-162016-07Eadon, M., Desta, Z., Levy, K., Decker, B., Pierson, R., Pratt, V., … Flockhart, D. (2016). Implementation of a Pharmacogenomics Consult Service to Support the INGENIOUS Trial. Clinical Pharmacology and Therapeutics, 100(1), 63–66. http://doi.org/10.1002/cpt.347https://hdl.handle.net/1805/15650Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.en-USPublisher PolicyAcademic medical centers/organization & administrationMedically uninsuredPharmacogenetics/organization & administrationPovertySafety-net providers/organization & administrationVulnerable populationsArticle